Ims

The Finance Bill is likely to introduce amendments to the GST Act to further strengthen mechanisms to curb fake invoicing. Sources said the act will be amended to include the Invoice Management System, introduced in November 2024 to curb fake invoicing, giving it a legal basis.

GST Council likely to approve rules for Invoice Management System to tackle fake invoicing, tax evasion

Rules for IMS have been prepared by the GST law committee. Businesses, particularly MSMEs, may face additional costs for IT upgrades and integrating IMS into their systems

Glenmark gets USFDA approval for Rufinamide tablets; up 2%

Glenmark Pharmaceuticals Inc. USA has been granted final approval by the United States Food and Drug Administration (USFDA) for its Rufinamide tablets USP, 200 mg and 400 mg.

Aurobindo Pharma gets USFDA nod for oral contraceptives

Drug firm Aurobindo Pharma has received final approval from the US health regulator to manufacture and market its oral contraceptive, Levonorgestrel tablets.

CLSA retains buy on HCL Tech, IMS to drive growth

The management has indicated concerns about margin growth. Its first half of FY16 margin is likely to be impacted by wage hikes, large deal transitions and onsite investments despite currency benefits.

Aurobindo Pharma gets USFDA nod to market ulcer drug

The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Omeprazole delayed-release capsules in the strengths of 10mg, 20mg and 40mg, Aurobindo Pharma said in a statement.

Mankind Pharma sees FY domestic sales topping $700 mn

Mankind Pharmaceuticals Pvt Ltd, one of India's top-ten drugmakers by sales, is willing to spend up to Rs 500 crore (USD80.30 million) to buy local rivals and is keen on licensing deals with foreign firms, a top official at the firm said.

Lupin launches generic hypertension drug in US

The US arm of the company, Lupin Pharmaceuticals Inc, has launched Amlodipine and Valsartan tablets in various strengths in the US market after getting final approval from the United States Food and Drug Administration (USFDA), Lupin said in a statement.

Europe remains growth driver, have 2-3 good deals: Hexaware

The technology company is not focused on margin expansion but growth and wants to reinvest margins back into multiple growth areas so that it is not focused on margin expansion dramatically

Wipro sinks as Q4 revenue growth, Q1 guidance disappoint

Wipro shares plunged more than 10 percent on Monday morning after investors slammed India's third largest software services exporter on weak revnue growth in the fourth quarter and muted guidance for April-June.

See medium-term margins in 18-19% range: HCL Tech

HCL Technologies' margins in the medium-term will be in the 18-19 percent range, CFO Anil Chanana said on Wednesday.

Prabhudas Lilladher remains cautious on HCL Tech

Prabhudas Lilladher has come out with its report on Information Technology (IT) sector update. The research firm see increased competition in IS outsourcing to exert pressure to outdo their rivals in terms of costs and deliverables.

VRL Media Adopts IBM's Integrated Managed Services

IBM will manage all infrastructure services to address the IT needs for the "Vijayvani" newspaper.

Alcatel-Lucent to open bids for $1bn IT deal in 1-2 months

In what can be the largest IT outsourcing deal from the telecom space, CNBC-TV18 learns that Alcatel-Lucent is likely to open bids for an IT deal worth USD 1 billion in the next one-two months.

Goldman Sachs may open IT contract worth $700-900 m

Goldman Sachs is likely to open IT contract worth USD 700-900 million, reports CNBC-TV18 quoting sources. It is learnt that the IT deal to handle application development infrastructure management services (IMS) in three geographies may span across 10 years.

Mobile Wallet roll out starts with small change

Virtual wallet technology that lets people pay for a coffee, newspaper or sandwich by swiping a cell phone at a checkout is finally set to start rolling out, executives told the Reuters Technology Summit this week in Paris.

Aurobindo gets Australia's TGA nod for 2 generic drugs

Aurobindo Pharma has got approval for its generic drugs, Risperidone and Alendronate tablets, used to treat schizophrenia and osteoporosis, respectively, from Australia’s Therapeutic Goods Administration, the company said in a press release to the stock exchanges Tuesday.